Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis.

Katarzyna KozakArtur KowalikAleksandra GosBartosz WasagIwona LugowskaMonika JurkowskaNatalia KrawczynskaHanna Kosela-PaterczykTomasz SwitajPaweł TeteryczAnna KlimczakJanusz A SiedleckiMałgorzata ChlopekJoanna KaliszJanusz LimonPiotr Rutkowski

Published in: Tumori (2020)

Monitoring of plasma BRAF p.V600E cfDNA concentrations in patients with metastatic melanoma on targeted therapy may have prognostic value. Undetectable cfDNA p.V600E before and during treatment was associated with a favorable prognosis.

Keyphrases

metastatic colorectal cancer
wild type
stem cells
bone marrow
smoking cessation